Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus
Author
Date
2023-01Permanent link
https://hdl.handle.net/11351/10621DOI
10.1016/j.rpsm.2020.04.013
ISSN
2950-2853
PMID
32561156
Abstract
Objective
This study aims to assess the validity of the ADHD module of the Mini-International Neuropsychiatric Interview (MINI-Plus) in patients with substance use disorders (SUD), using the Conners’ Adult ADHD Diagnostic Interview for DSM-IV (CAADID) as the external criterion.
Method
A cross sectional international multi-center study in 10 countries was conducted in treatment seeking SUD patients. A sample of 1263 patients with both MINI-Plus and CAADID was analyzed to determine the psychometric properties of the MINI-Plus.
Results
According to the CAADID, 179 patients (14.2%) met criteria for adult ADHD, whereas according to the MINI-Plus 227 patients (18.0%) were identified as having adult ADHD. Sensitivity of the MINI-Plus ADHD module was 74%, specificity was 91%, positive predictive value was 60% and negative predictive value was 96%. Kappa was 0.60.
Conclusion
The MINI-Plus has acceptable criterion validity for the screening of adult ADHD in treatment seeking SUD patients.
Scientific significance
On the basis of the results, The MINI-Plus may be used for the screening of ADHD in SUD patients.
Keywords
Comorbidity; Psychometrics; Substance use disorderBibliographic citation
Palma-Álvarez RF, Barta C, Carpentier PJ, Carruthers S, Crunelle CL, Demetrovics Z, et al. Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus. Span J Psychiatry Ment Heal. 2023 Jan-Mar;16(1):11–5.
Audience
Professionals
This item appears in following collections
- HVH - Articles científics [4466]
The following license files are associated with this item:





